image
BioMarin Pharmaceutical Inc. BMRN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 70.925
-0.33 %
$ 13.5 B
Market Cap
32.09
P/E
CASH FLOW STATEMENT
573 M OPERATING CASH FLOW
259.69%
Growth Rates
1Year 259.69%
3Years 23.44%
5Years 64.02%
7Years 82.50%
10Years 25.63%
136 M INVESTING CASH FLOW
222.70%
Growth Rates
1Year 222.70%
3Years 33.38%
5Years 44.95%
7Years 13.64%
10Years -3.48%
-526 M FINANCING CASH FLOW
-2711.17%
Growth Rates
1Year -2711.17%
3Years -2121.80%
5Years -47.79%
7Years -10.71%
10Years -14.39%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis BioMarin Pharmaceutical Inc.
image
Net Income 427 M
Depreciation & Amortization 88.1 M
Capital Expenditures -85.4 M
Stock-Based Compensation 202 M
Change in Working Capital 0
Others -200 M
Free Cash Flow 487 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
OPERATING CASH FLOW
Net Income 426.9 167.6 141.6 (64.1) 859.1 (23.8) (77.2) (117.0) (630.2) (171.8) (134.0) (176.4) (114.3) (53.8) 205.8 (0.5) 30.8 (15.8) (28.5) (74.3) (187.4) (76.4) (77.4) (57.4) (37.4) (28.1) (12.3)
Depreciation & Amortization 88.1 104.4 102.0 108.0 105.2 105.3 95.7 87.9 96.9 47.2 56.7 47.3 45.3 36.1 27.7 21.0 17.6 1.1 12.0 10.1 13.3 9.4 8.5 7.0 7.3 6.6 0.8
Deferred Income Tax 56.1 (45.0) (52.1) (15.6) (888.9) (82.8) (68.4) 44.5 (228.1) (76.8) (25.5) (9.2) (9.9) 4.4 (230.6) 9.3 3.0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 201.6 207.1 196.3 197.3 189.7 159.9 148.8 140.3 134.6 111.5 88.2 66.2 47.3 43.9 38.4 36.0 28.3 0 0 0 0 0 0 0 0 0 0
Other Operating Activities (199.8) 61.6 (115.5) 12.9 44.7 (9.2) (29.3) (70.3) 559.1 (178.1) (28.7) 35.5 16.2 13.3 19.5 2.0 15 K (6.6) (4.0) (6.0) 104.8 (1.6) 17.2 30.1 16.4 7.0 2.6
Change in Working Capital 0 (336.5) (96.4) 66.0 (224.4) (101.1) (49.4) (94.0) (160.3) 46.3 (30.3) (23.1) 33.1 (25.1) (42.1) 19.9 (89.0) (13.2) (29.5) 7.5 4.3 (6.3) (2.0) (2.7) 0.7 1.6 0.8
Cash From Operations 572.8 159.3 175.9 304.5 85.4 48.3 20.2 (8.8) (227.8) (221.7) (73.5) (59.6) 17.6 18.8 18.7 87.7 (9.2) (34.5) (50.1) (62.7) (65.1) (74.8) (53.6) (23.1) (12.9) (12.9) (8.1)
INVESTING CASH FLOW
Capital Expenditures (85.4) (107.6) (131.5) (119.2) (137.5) (163.4) (144.6) (199.2) (148.4) (227.7) (118.8) (65.1) (44.6) (154.2) (49.5) (89.8) (56.4) (22.4) (24.6) (3.0) (24.1) (6.0) (4.9) (17.8) (3.8) (22.9) (6.4)
Other Items 221.9 (3.6) 111.5 (247.1) 83.9 132.4 409.0 (106.2) (335.7) (951.9) 313.4 (233.7) (151.1) 64.7 (51.9) 10.1 37.3 (128.6) (170.2) 60.6 8.8 (45.0) 75.8 (116.1) 2.2 (45.8) (1.8)
Cash From Investing Activities 136.5 (111.2) (20.0) (366.3) (53.6) (31.0) 264.4 (305.5) (484.0) (1 179.6) 194.6 (298.8) (195.6) (89.6) (101.3) (79.7) (19.1) (151.0) (194.8) 57.6 (15.3) (51.0) 70.9 (133.9) (1.6) (68.8) (8.2)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 (54.3) (45.8) (50.0) (42.7) (35.9) (33.5) 0 0 0 (6.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 (2.3) (2.6) (3.0) 203.8 (5.1) (375.0) 481.7 0 0 0 713.2 0 (0.9) (0.2) (74.8) 94 K 309.4 163.1 0.2 0.3 118.4 0.2 5.3 0.8 25.6 100 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (526.4) (85.8) (16.0) 3.0 27.3 (69.6) (13.1) 25.5 14.2 39.7 68.9 33.4 76.8 (3.4) 3.7 11.0 22.9 0 (7.7) 22.1 (30.0) 0.5 1.8 13.2 0 0 100 K
Cash From Financing Activities (526.4) (18.7) (18.6) 48 K 181.1 (74.7) (388.0) 507.1 727.1 927.9 185.7 746.7 312.3 29.0 3.5 (63.8) 22.8 324.6 295.9 30.1 (27.9) 213.5 3.8 153.0 7.6 95.7 19.7
CHANGE IN CASH
Net Change In Cash 187.7 30.6 137.3 (61.9) 211.7 (56.5) (104.0) 189.7 11.3 (478.4) 306.7 388.3 134.3 (41.8) (79.1) (55.7) (5.4) 139.2 51.1 25.0 (108.3) 87.8 21.1 (4.0) (6.9) 14.0 3.4
FREE CASH FLOW
Free Cash Flow 487.4 51.6 44.4 185.3 (52.2) (115.1) (124.4) (208.0) (376.2) (449.3) (192.4) (124.8) (27.0) (135.5) (30.7) (2.1) (65.5) (56.9) (74.7) (65.6) (89.2) (80.8) (58.5) (40.9) (16.7) (35.9) (14.5)